State Street
DWTX

State Street’s Dogwood Therapeutics DWTX Stock Holding History

State Street’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,113
Closed -$8.98K – 4326
2024
Q3 		$8.98K Hold
2,113
– – ﹤0.01% 4268
2024
Q2 		$11.4K Hold
2,113
– – ﹤0.01% 4319
2024
Q1 		$25.3K Hold
2,113
– – ﹤0.01% 4265
2023
Q4 		$30.4K Hold
2,113
– – ﹤0.01% 4282
2023
Q3 		$48.9K Hold
2,113
– – ﹤0.01% 4297
2023
Q2 		$72.9K Buy
2,113
+1,688
+397% +$48.1K ﹤0.01% 4309
2023
Q1 		$3.91K Hold
425
– – ﹤0.01% 4773
2022
Q4 		$2.51K Hold
425
– – ﹤0.01% 4850
2022
Q3 		$4K Hold
425
– – ﹤0.01% 4921
2022
Q2 		$45K Buy
+425
New +$44.4K ﹤0.01% 4744

Other funds holding DWTX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

State Street's DWTX Position: Q4 2024 in Review

State Street sold out of Dogwood Therapeutics (DWTX) in Q4 2024, closing a stake of 2,113 shares — an estimated $8.98K sold.

State Street first reported a position in DWTX in Q2 2022 and held it in 10 quarters. The position peaked at $72.9K in Q2 2023. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2024.

  • State Street reported no remaining Dogwood Therapeutics position as of Q4 2024 after selling out during the quarter.
  • State Street sold 2,113 Dogwood Therapeutics shares in Q4 2024, an estimated $8.98K.
  • State Street first reported a position in Dogwood Therapeutics in Q2 2022 and held it in 10 quarters.
  • State Street's Dogwood Therapeutics position peaked at $72.9K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2024.

Based on State Street's 13F filing for Q4 2024, filed 14 Feb 2025.